U.S. Surgical Sutures Market Size, Share & COVID-19 Impact Analysis, By Product Type (Absorbable and Non-Absorbable), By Form (Natural and Synthetic), By Application (Gynecology, Cardiology, Orthopedics, General Surgery, and Others), By End-user (Hospitals & ASCS and Specialty Clinics), and Country Forecast, 2023-2030

The U.S. surgical sutures market size was valued at USD 1.84 billion in 2022 and is projected to grow at a CAGR of 5.8% during the forecast period. 

Surgical sutures are mainly used in wound closure in all types of surgical procedures, such as joint replacement, c-section, and appendectomy, along with minor surgeries, such as cataract surgery, dental surgery, and others. The increasing patient pool undergoing joint replacement surgeries plays an important role in propelling the market’s growth.

• For instance, according to an article published in Agappe in November 2022, 260,000 to 300,000 hospitalizations for hip fractures are estimated annually in the U.S. The number is projected to reach 500,000 by 2040.

With this growing demand for surgical sutures, the market players have shifted their focus on the development of innovative, and technologically advanced products to capture the untapped avenues of the market.

The COVID-19 pandemic resulted in a decline in elective procedures due to the measures taken to contain the spread of the virus. However, with the ease of lockdown restrictions, the market regained its pace in 2021 and returned to pre-pandemic growth in 2022.

LATEST TRENDS

Manufacturers’ Focus on Innovative Products Launches is a Prominent U.S. Surgical Sutures Market Trends

In recent years, surgical sutures are witnessing an exponential increase in demand. The increasing number of surgical procedures performed every year in the country has been noticed. To capture this growing demand, manufacturers focus on the development and launch of advanced and innovative sutures. Some of the innovative sutures include electronic, knotless, and elastic sutures.

• For instance, in September 2020, HELICOIL knotless suture was introduced by Smith & Nephew. This product was aimed at improving the healing process.

DRIVING FACTORS

High Number of Surgical Procedures in the U.S. to Boost the Surgical Sutures Market Growth

In the U.S., the incidences of chronic conditions requiring surgical interventions, along with the number of road accident cases, trauma injuries, and others is constantly increasing. This has resulted in an increasing number of surgeries being performed in hospitals, clinics, and ambulatory surgical centers (ASCs). Some common surgical procedures include appendectomy, carotid endarterectomy, cesarean section, and others.

• For instance, according to Centers for Disease Control and Prevention (CDC) data, in 2021, the number of cesarean deliveries in the U.S. was 1,174,545, which accounted for 32.1% of all deliveries.

Furthermore, the increasing geriatric population in the country is also supplementing the market growth in the U.S. by increasing the demand for surgeries, such as joint replacement, organ transplant, coronary bypass, and others.

Download Free sample to learn more about this report.

According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2022, the number of major adult cardiac surgery procedures in the U.S. reached to 211, 533 in 2021 with an increase of 10.5% compared to 2020 statistics.

RESTRAINING FACTORS

Availability of Alternative Treatment Options to Impede Growth Prospects

One of the key factors limiting the U.S. market growth includes the easy availability of alternative wound healing options in the country. Additionally, post-surgical complications associated with the use of sutures further impede the growth of the market in the U.S.

Surgical staplers, one of the alternatives to surgical sutures, are being increasingly adopted in the market. This is due to several advantages of surgical staplers, such as better wound healing capability, comparatively low cost, and others.

SEGMENTATION

By Product Type Analysis

Based on product type, the market is bifurcated into absorbable and non-absorbable.

The absorbable sutures segment accounted for the largest U.S. surgical sutures market share in 2022. The dominance of this segment can be attributed to the increasing adoption of these sutures owing to several benefits they offer. Some of the benefits include reduced tissue reaction, enhanced wound healing, versatility in terms of size & configuration, reduced patient discomfort, and others.

The non-absorbable suture segment is anticipated to witness moderately sluggish growth in the coming years. This is majorly owed to the high post-operative care and high level of patient discomfort, resulting in lesser adoption of non-absorbable sutures.

By Form Analysis

Based on form, the market is bifurcated into synthetic and natural.

In 2022, the synthetic sutures segment dominated the U.S. surgical sutures market owing to the comparatively low cost and reduced tissue reactivity due to the smooth surface.  In addition, the wide availability of these sutures also supports segment growth.

The natural sutures segment is projected to witness a lower CAGR over the study period. This is due to the property of natural sutures to react to the surrounding tissues after closing the wound.  The high tissue reactivity results in lower product adoption.

By Application Analysis

Based on application, the market is categorized into gynecology, cardiology, orthopedics, general surgery, and others.

The orthopedics segment accounted for the highest market share in 2022. This can be attributed to the growing number of orthopedic procedures coupled with an increasing prevalence of orthopedic disorders in the country. The segment is also expected to dominate the market in the coming years.

• For instance, according to an article published by Regenexx in July 2021, in the U.S., around 7 million orthopedic surgeries are performed every year.

The cardiology segment is expected to witness a significant growth during the forecast period. Factors such as the increasing prevalence of cardiovascular diseases leading to a rising need for cardiac-related surgeries are driving the growth of this segment.

By End-user Analysis

Based on end-user, the market is segmented into hospitals & ASCs and specialty clinics.

In 2022, the hospitals & ASCs segment held the leading market share and is anticipated to continue its dominance during the forecast period. The high number of surgical procedures performed in hospitals, coupled with the increasing adoption of technologically advanced products by the U.S. hospitals, drives the segment’s growth. In addition, ASCs are also witnessing increasing patient flow in recent years, which is driving segment growth.

The specialty clinics segment is estimated to grow notably in the coming years. The growing number of these clinics in the country, along with the increasing patient pool for elective surgeries, is expected to boost segment growth.

KEY INDUSTRY PLAYERS

Few well-established players dominate the competitive space for the U.S. market. Some of these players include Medtronic, B. Braun SE, and Johnson & Johnson Services, Inc. These companies account for a significant market share. A strong focus on the launch of technologically advanced products coupled with a wide portfolio of these companies are some of the factors contributing to their market dominance.

• For instance, in January 2021, Allergan Aesthetics, an AbbVie company, introduced CoolSculpting Elite for the treatment of fat bulges in nine areas of the body.

Some other key players operating in the U.S. market. include Stryker, CONMED Corporation, Smith & Nephew, Boston Scientific Corporation, Peters Surgical, and others. These companies are undertaking various strategic initiatives such as new product launches, collaborations, and others to improve their market presence.

• For instance, in December 2022, Citrefix Suture Anchor System for foot and ankle surgeries was introduced by Stryker.

LIST OF KEY COMPANIES PROFILED:

• B. Braun SE (Germany)
• Johnson & Johnson Services, Inc. (MENTOR) (U.S.)
• Smith & Nephew (U.K.)
• Medtronic (Ireland)
• Boston Scientific Corporation (U.S.)
• Stryker (U.S.)
• DemeTECH Corporation (U.S.)
• TEPHA INC. (U.S.)
• Coloplast A/S (Denmark)

KEY INDUSTRY DEVELOPMENTS: 

• September 2022: The U.S. FDA provided 510(k) clearance for Mesh Suture, Inc.’s DURAMESH non-absorbable polypropylene mesh suture.
• July 2021: Via Surgical received the U.S. FDA approval for its closed-loop suture-based fixation system named TissueTak tendon anchor.
• February 2021: Acuitive Technologies received the U.S. FDA clearance for its CITREFIX knotless suture anchor system. This product is made from a bioresorbable synthetic polymer.

REPORT COVERAGE

An Infographic Representation of U.S. Surgical Sutures Market

View Full Infographic

To get information on various segments, share your queries with us

The U.S. surgical sutures market research report provides a detailed analysis of the market. It focuses on key market segments such as product type, form, application, and end-user. Additionally, it includes detailed insights on market dynamics, new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. The report also provides the competitive landscape of the key companies at the U.S. level.

Report Scope & Segmentation